News

Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...
Is Zepbound or Wegovy better for weight loss? First-of-its-kind study offers answer
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Technology Networks20h
Zepbound Outcompetes Wegovy for Weight Loss in Head-to-Head Trials
Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the ...
Popular injected weight loss medications work better for one sex. Researchers want to know why
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
Everyday Health on MSN1d
Zepbound Beats Wegovy for Weight Loss in First Head-to-Head Trial
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Zepbound beats Wegovy for weight loss in trial of blockbuster drugs
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...